EMERA INCORPORATED (EMA) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2025-12-31..
- Stock-based compensation / revenue · 12 months: Value (m); Formula and calculation Share-based compensation / revenue. Period ending 2025-12-31..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated CAD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2025-12-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2025-12-31. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | (m) | Share-based compensation / revenue. Period ending 2025-12-31. Calculation unavailable: missing inputs remain (m). |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated CAD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | 8.78B CAD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | (m) | |
| Operating income | 1.98B CAD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (CAD) | Revenue (CAD) | Stock-based compensation (CAD) | Operating income (CAD) | Interest expense · reported / estimated (CAD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | (m) | 8.78B | (m) | 1.98B | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | 7.20B | (m) | 1.08B | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | 7.56B | (m) | 1.79B | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | 7.59B | (m) | 1.63B | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | 5.76B | (m) | 930.00M | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | 5.51B | (m) | 1.15B | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | 6.11B | (m) | 1.34B | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | (m) | 6.52B | (m) | 1.40B | 724.00M | (m) | (m) | 1.93× | Reported |
| 2017-12-31 | (m) | 6.23B | (m) | 1.39B | 705.00M | (m) | (m) | 1.97× | Reported |
| 2016-12-31 | (m) | 4.28B | (m) | 555.00M | 600.00M | (m) | (m) | 0.93× | Reported |
| 2015-12-31 | (m) | 2.79B | (m) | 508.00M | 222.00M | (m) | (m) | 2.29× | Reported |
| 2011-12-31 | (m) | 2.06B | (m) | 317.50M | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | 1.61B | (m) | 312.20M | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.